Kiora Pharmaceuticals, Inc. (KPRX)
2.49
-0.02
(-0.80%)
USD |
NASDAQ |
Sep 09, 15:06
Kiora Pharmaceuticals Total Assets (Quarterly) : 23.78M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.78M |
| March 31, 2026 | 21.23M |
| December 31, 2025 | 24.25M |
| September 30, 2025 | 29.86M |
| June 30, 2025 | 31.95M |
| March 31, 2025 | 34.02M |
| December 31, 2024 | 36.48M |
| September 30, 2024 | 38.51M |
| June 30, 2024 | 40.81M |
| March 31, 2024 | 42.44M |
| December 31, 2023 | 13.71M |
| September 30, 2023 | 15.90M |
| June 30, 2023 | 19.88M |
| March 31, 2023 | 16.53M |
| December 31, 2022 | 18.68M |
| September 30, 2022 | 17.66M |
| June 30, 2022 | 15.46M |
| March 31, 2022 | 17.64M |
| December 31, 2021 | 20.13M |
| September 30, 2021 | 25.49M |
| June 30, 2021 | 18.10M |
| March 31, 2021 | 20.62M |
| December 31, 2020 | 15.30M |
| September 30, 2020 | 9.245M |
| June 30, 2020 | 10.97M |
| Date | Value |
|---|---|
| March 31, 2020 | 12.19M |
| December 31, 2019 | 10.11M |
| September 30, 2019 | 8.868M |
| June 30, 2019 | 10.90M |
| March 31, 2019 | 12.44M |
| December 31, 2018 | 14.28M |
| September 30, 2018 | 16.65M |
| June 30, 2018 | 19.06M |
| March 31, 2018 | 11.17M |
| December 31, 2017 | 14.31M |
| September 30, 2017 | 16.06M |
| June 30, 2017 | 18.37M |
| March 31, 2017 | 12.06M |
| December 31, 2016 | 9.789M |
| September 30, 2016 | 10.68M |
| June 30, 2016 | 12.84M |
| March 31, 2016 | 12.38M |
| December 31, 2015 | 9.566M |
| September 30, 2015 | 10.14M |
| June 30, 2015 | 1.615M |
| March 31, 2015 | 2.606M |
| December 31, 2014 | 1.465M |
| September 30, 2014 | 1.668M |
| June 30, 2014 | 1.163M |
| March 31, 2014 | 0.7326M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.919M |
| Shareholders Equity (Quarterly) | 16.86M |
| Debt to Equity Ratio | 0.0198 |
| Current Ratio | 8.970 |
| Net Debt Paydown Yield | -0.30% |